•  
  •  
 

Abstract

The aftermath of a traumatic brain injury is characterized by a state of disruption, progressing into secondary injury and culminating in a complex network of interconnected pathophysiological disturbances.  The potential risk of developing neurological disorders after TBI highlights the pressing need to enhance our understanding and develop therapeutic in-terventions to alleviate its devastating consequences. Traumatic brain injury can lead to a range of problems, including pain, swelling, axonal degeneration, and chronic amnestic and non-amnestic cognitive impairments. The first and essential step in the management of TBI is to identify and characterize the clinical symptoms. This systematic review outlines the established frameworks for classifying brain injuries and the comprehensive clinical assessment tools for evaluating the stages of neurotrauma. Besides, the review highlights the potential of protein biomarkers identified by state-of-the-art neuroimaging techniques as a tool to identify asymptomatic individuals at risk of neurodegeneration. In view of the he-terogeneous clinical presentation of TBI, the following sections include a description of the various animal models de-veloped to recapitulate the effects of TBI, the pathophysiological changes are considered promising targets for future therapeutic interventions, and the current and prospective treatment and management approaches for this invisible disease.

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.